Patents by Inventor Malu Lourdes G. Tansey

Malu Lourdes G. Tansey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
    Patent number: 7244823
    Abstract: The invention relates to novel proteins with TNF-alpha antagonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of TNF-alpha related disorders.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: July 17, 2007
    Assignee: Xencor
    Inventors: Bassil I. Dahiyat, John R. Desjarlais, Anton Filikov, Umesh Muchhal, Malu Lourdes G. Tansey, Jonathan Zalevsky
  • Dominant negative proteins and methods thereof
    Publication number: 20040170602
    Abstract: The invention relates to novel proteins with TNFSF antagonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of TNFSF-related disorders.
    Type: Application
    Filed: July 1, 2003
    Publication date: September 2, 2004
    Inventors: John R. Desjarlais, Malu Lourdes G. Tansey, Bassil I. Dahiyat
  • Dominant negative proteins and methods thereof
    Publication number: 20030166559
    Abstract: The invention relates to novel proteins with TNFSF antagonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of TNFSF-related disorders.
    Type: Application
    Filed: January 6, 2003
    Publication date: September 4, 2003
    Inventors: John R. Desjarlais, Malu Lourdes G. Tansey, Bassil I. Dahiyat
  • Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
    Publication number: 20030138401
    Abstract: The invention relates to novel proteins with TNF-alpha antagonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of TNF-alpha related disorders.
    Type: Application
    Filed: September 30, 2002
    Publication date: July 24, 2003
    Inventors: Bassil I. Dahiyat, John R. Desjarlais, Anton Filikov, Umesh Muchhal, Malu Lourdes G. Tansey, Jonathan Zalevsky